Levocetirizine Dihydrochloride Tablet
Product Images NDC 31722-551

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 31722-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber1

FDA Label Image

Label

Label
This is a description of Levocetirizine Dihydrochloride S+t tablets, which come in a pack of 30 and are prescription-only. The usual dosage is recommended, however, it is not clearly stated in the provided text. The rest of the text is not available as it contains non-English characters and also appears to be cut off mid-sentence.*
FDA Label Image

Levocitirizine5mg30scount

Levocitirizine5mg30scount
Each film-coated tablet contains 5mg of Levocetirizine dihydrochloride, USP. The usual dosage should be obtained from the package insert for complete dosage recommendations. Levocetirizine should be stored in a tight, light-resistant container at room temperature. The tablets are manufactured by Amber Pharmaceuticals, Inc. for Anora Pharma Pvt Ltd. in Telangana, India. This medication is only available by prescription.*
FDA Label Image

Levocitirizinestructure

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.